IBDEI1KC ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24982,1,3,0)
 ;;=3^Family Hx of Leukemia
 ;;^UTILITY(U,$J,358.3,24982,1,4,0)
 ;;=4^Z80.6
 ;;^UTILITY(U,$J,358.3,24982,2)
 ;;=^5063354
 ;;^UTILITY(U,$J,358.3,24983,0)
 ;;=Z80.8^^107^1212^30
 ;;^UTILITY(U,$J,358.3,24983,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24983,1,3,0)
 ;;=3^Family Hx of Malig Neop of Organs/Systems
 ;;^UTILITY(U,$J,358.3,24983,1,4,0)
 ;;=4^Z80.8
 ;;^UTILITY(U,$J,358.3,24983,2)
 ;;=^5063356
 ;;^UTILITY(U,$J,358.3,24984,0)
 ;;=Z81.8^^107^1212^35
 ;;^UTILITY(U,$J,358.3,24984,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24984,1,3,0)
 ;;=3^Family Hx of Mental/Behavioral Disorders
 ;;^UTILITY(U,$J,358.3,24984,1,4,0)
 ;;=4^Z81.8
 ;;^UTILITY(U,$J,358.3,24984,2)
 ;;=^5063363
 ;;^UTILITY(U,$J,358.3,24985,0)
 ;;=Z82.3^^107^1212^42
 ;;^UTILITY(U,$J,358.3,24985,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24985,1,3,0)
 ;;=3^Family Hx of Stroke
 ;;^UTILITY(U,$J,358.3,24985,1,4,0)
 ;;=4^Z82.3
 ;;^UTILITY(U,$J,358.3,24985,2)
 ;;=^5063367
 ;;^UTILITY(U,$J,358.3,24986,0)
 ;;=Z82.49^^107^1212^24
 ;;^UTILITY(U,$J,358.3,24986,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24986,1,3,0)
 ;;=3^Family Hx of Ischemic Heart Disease/Circulatory System
 ;;^UTILITY(U,$J,358.3,24986,1,4,0)
 ;;=4^Z82.49
 ;;^UTILITY(U,$J,358.3,24986,2)
 ;;=^5063369
 ;;^UTILITY(U,$J,358.3,24987,0)
 ;;=Z82.5^^107^1212^14
 ;;^UTILITY(U,$J,358.3,24987,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24987,1,3,0)
 ;;=3^Family Hx of Asthma/Chronic Lower Respiratory Diseases
 ;;^UTILITY(U,$J,358.3,24987,1,4,0)
 ;;=4^Z82.5
 ;;^UTILITY(U,$J,358.3,24987,2)
 ;;=^5063370
 ;;^UTILITY(U,$J,358.3,24988,0)
 ;;=Z82.61^^107^1212^13
 ;;^UTILITY(U,$J,358.3,24988,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24988,1,3,0)
 ;;=3^Family Hx of Arthritis
 ;;^UTILITY(U,$J,358.3,24988,1,4,0)
 ;;=4^Z82.61
 ;;^UTILITY(U,$J,358.3,24988,2)
 ;;=^5063371
 ;;^UTILITY(U,$J,358.3,24989,0)
 ;;=Z82.69^^107^1212^37
 ;;^UTILITY(U,$J,358.3,24989,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24989,1,3,0)
 ;;=3^Family Hx of Musculoskeletal System/Connective Tissue
 ;;^UTILITY(U,$J,358.3,24989,1,4,0)
 ;;=4^Z82.69
 ;;^UTILITY(U,$J,358.3,24989,2)
 ;;=^5063373
 ;;^UTILITY(U,$J,358.3,24990,0)
 ;;=Z83.3^^107^1212^20
 ;;^UTILITY(U,$J,358.3,24990,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24990,1,3,0)
 ;;=3^Family Hx of Diabetes Mellitus
 ;;^UTILITY(U,$J,358.3,24990,1,4,0)
 ;;=4^Z83.3
 ;;^UTILITY(U,$J,358.3,24990,2)
 ;;=^5063379
 ;;^UTILITY(U,$J,358.3,24991,0)
 ;;=Z83.2^^107^1212^16
 ;;^UTILITY(U,$J,358.3,24991,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24991,1,3,0)
 ;;=3^Family Hx of Blood/Immune Mechanism Diseases
 ;;^UTILITY(U,$J,358.3,24991,1,4,0)
 ;;=4^Z83.2
 ;;^UTILITY(U,$J,358.3,24991,2)
 ;;=^5063378
 ;;^UTILITY(U,$J,358.3,24992,0)
 ;;=Z82.71^^107^1212^40
 ;;^UTILITY(U,$J,358.3,24992,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24992,1,3,0)
 ;;=3^Family Hx of Polycystic Kidney
 ;;^UTILITY(U,$J,358.3,24992,1,4,0)
 ;;=4^Z82.71
 ;;^UTILITY(U,$J,358.3,24992,2)
 ;;=^321531
 ;;^UTILITY(U,$J,358.3,24993,0)
 ;;=Z82.1^^107^1212^15
 ;;^UTILITY(U,$J,358.3,24993,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24993,1,3,0)
 ;;=3^Family Hx of Blindness/Visual Loss
 ;;^UTILITY(U,$J,358.3,24993,1,4,0)
 ;;=4^Z82.1
 ;;^UTILITY(U,$J,358.3,24993,2)
 ;;=^5063365
 ;;^UTILITY(U,$J,358.3,24994,0)
 ;;=Z82.2^^107^1212^19
 ;;^UTILITY(U,$J,358.3,24994,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24994,1,3,0)
 ;;=3^Family Hx of Deafness/Hearing Loss
